Haleos Labs Ltd

NSE: HALEOSLABS · BSE: 540679 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹1,587.00
Market cap: ₹479.8 Cr
Revenue (annual): ₹333.8 Cr
Net profit (annual): ₹17.31 Cr
P/E (TTM): 30.4×Sector 47.4×
Promoter holding: 72.11%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 4 Other Announcement 1 Management Change 1 Financial Results 1 Dividend 1 Business Update 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

5 Aug 2026 14:33 IST BSE

Management Change

Haleos Labs Management Change

Haleos Labs Limited has re-appointed Dr. Mannam Malakondaiah and Dr. Srinivas Samavedam as Independent Directors for five-year terms starting November 13, 2026. Shareholder approval is required.

Execution: 5 years

Read the filing ↗